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The aim of this study was to examine the progression of kidney damage induced by zinc deficiency in 
diabetic rats and to evaluate the effect of combined treatment of vitamin E and vitamin C in renal injury 
by providing protection against deleterious action of zinc deficiency.  Female diabetic albino Wistar rats 
were randomly assigned into five groups. The first group  received a diet containing a 54 mg zinc/kg 
diet (adequate zinc, AZ), the second  group  received a diet containing 1 mg zinc/kg diet (zinc deficient 
group, ZD), and the three other groups received ZD diet and treated orally with vitamin E (500 mg/kg 
body wt) (ZD + Vit E), vitamin C (500 mg/kg body wt) (ZD + Vit C), and combined vitamins C and E (250 + 
250 mg/kg body wt) (ZD+VitC+VitE), respectively. Body weight was recorded regularly (twice weekly). 
After four weeks of dietary manipulation, kidney zinc level, serum albumin and total protein 
concentration of ZD group were significantly lower than those of AZ group. Dietary zinc deficiency also 
increased proteinuria excretion, serum and urinary urea and uric acid levels, serum creatinine and 
kidney malondialdehyde concentration. In contrast, the catalase activity and reduced glutathione level 
in the kidney were reduced. In conclusion, vitamins E and C act as beneficial antioxidants protect renal 
function against the noticed oxidative stress due to zinc deficiency and experimental diabetes. 
 





Zinc is one of the most important essential metals for 
human nutrition. It is important for cellular processes, like 
genetic expression, cell division, and growth. This trace 
element is crucial for the function of more than 300 
enzymes (Salgueiro et al., 2000; Jansen et al., 2009) and 
plays an important role in insulin action, carbohydrate 
and protein metabolism (Chausmer, 1998). Zinc defi-
ciency has been reported to impact pancreatic function 
(Banavara et al., 2011) and appears to decrease the 
ability of the pancreas to respond to glucose, eventually
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leading to islet cell damage (Chiara et al., 2007). Zinc 
status was proposed to play a key role in the onset 
and/or progression of diabetes (Miao et al., 2013), as 
supported by several examples in both man and rodent 
models (Taylor, 2005). According to the study of Faurea 
et al. (2007), several complications of diabetes may be 
related to increased intracellular oxidants and free 
radicals associated with decreases in intracellular zinc 
and zinc-dependent antioxidant enzymes.  Therefore, 
abnormal zinc metabolism could play a role in the 
pathogenesis of diabetes mellitus, wich is accom-panied 
by sever oxidative stress as a result of an increase 
oxygen free radical production.  
Increased oxidative stress in diabetes is postulated to 
promote the development of myocardial injury, neuro-
pathy, retinopathy and nephropathy (Kowluru et al., 
2007). Diabetic nephropathy is a leading cause of end 
stage renal disease. It is characterized functionally by 
proteinuria and albuminuria and pathologically by glome-
rular hypertrophy, mesangial expansion and tubulointer-
stitial fibrosis; these findings are closely related to the 
loss of renal function (Eun et al., 2007). Because this 
damage occurs as a result of increased reactive oxygen 
species  production, extensive investigation has evalua-
ted the ability of antioxidants like vitamin C and vitamin E 
to ameliorate complications of diabetes (Robert et al., 
2010).  
Vitamins C and E can be used as antioxidants 
separately or in combination. Both vitamins act synergisti-
cally to decreased renal oxidative stress, and kidney 
damage, and increased renal hemodynamics. In addition, 
vitamins C and E improve vascular function and structure, 
and prevent progression of diabetic complica-tions. Thus, 
the aim of this study was to examine the combined 
effects of vitamins C and E on kidney damage due to zinc 
defficiency in diabetic rats. We measured markers of 
oxidative stress and antioxidant state, serum and urinary 
parameters of renal function. 
 
 




Alloxan, 5, 5′dithiobis-(2-nitrobenzoic acid (DTNB), vitamin E (α-
tocopherol), and vitamin C were purchased from Sigma Chemical 
Co (St Louis, France). All other chemicals used in the experiment 





Female albino (Wistar) rats of 10 weeks of age, weighing 200 -250 
g, were obtained from Pasteur Institute (Algiers, Algeria). Animals 
were acclimated for one week under the same laboratory conditions 
of photoperiod (12 h light/12 h dark) with a relative humidity of 40% 
and room temperature of 22 ± 2°C. Standard rat food and deionized 
water were available ad-libitum. 
 
 
Induction of diabetes and diet 
 
Diabetes was induced with fresh alloxan monohydrate solution 
using a previously described method (Pathak et al., 2011). Alloxan  




was intraperitoneally administered at a dose of 150 mg/kg body 
weight dissolved in citrate buffer (0.01 M, pH 4.5). Blood glucose 
was measured seven days after induction of diabetes on samples 
taken from tail vein. The diabetic state was confirmed by a glucose-
meter (ACCU-CHEK, Roche Diagnostics, Paris, France) when the 
glucose concentration exceeded 14 mmol/l. 
The diet for rats consisted of (in g/kg diet): Cornstarch 326, 
sucrose 326, protein 168 (egg white solids), lipids 80 (corn oil), fiber 
40 (cellulose), vitamin mix (sigma) and mineral mix 40. The latter 
was formulated to contain either adequate (54 mg/kg) or deficient 
(1.2 mg/kg) quantities of Zn, as determined by atomic absorption 
spectroscopy. The mineral mix  supplied (in g /kg diet) calcium 
hydrogen orthophosphate 13; disodium hydrogen orthophosphate 
7.4; calcium carbonate 8.2; potassium chloride 7.03; magnesium 
sulphate 4; ferrous sulphate 0.144; copper sulphate 0.023; 
potassium iodide 0.001, manganese sulphate0.180 and zinc 






The rats were randomly assigned into five groups of 8 animals 
each. The first group received a diet containing a 54 mg zinc/kg diet 
(adequate zinc, AZ) (Southon et al., 1988), the second group 
received a diet containing 1 mg zinc/kg diet (zinc deficient group, 
ZD) for 28 days. The third and the fourth groups received ZD diet 
and treated orally with vitamin E (500 mg/kg) (ZD + VE) (Demiralay 
et al., 2007) and vitamin C (500mg/kg) (ZD+VC) (Kaida et al, 2010) 
respectively. The fifth group received ZD diet and in combination 
vitamins C and E (250 + 250 mg/kg body weight) (ZD+VC+VE) 
(Yanardag et al., 2007). The experimental procedures were carried 
out according to the National Institute of Health Guide-lines for 






At the end of the experiment, the rats were placed in metabolic 
cages and 24-h urine was collected for the measurement of urinary 
protein, urea and uric acid. 
 
 
Blood collection and preparation of tissue samples 
 
At the end of the experimental period (28 days) after overnight fast, 
rats were decapitated and blood samples were transferred into ice 
cold centrifuge tubes. The serum was prepared by centrifugation, 
for 10 min at 3000 revolutions/min and utilized for total protein, 
albumin, creatinine, urea and uric acid assays. Absolute kidney 
weight was determined, one fragment of kidney was rapidly 
excised, weighed, freeze-clamped at -196°C, ground under liquid 
nitrogen and stored at -20°C for oxidative stress parameters 
analysis, the second fragment was washed with isotonic saline (9 g 
sodium chloride/l distilled water) and blotted to dry at 80°C for 16 h 
and zinc concentration was determined. 
 
 




Total protein and albumin level in serum were determined with 
commercial kits from Spinreact, Spain, refs; total protein- 100129 
and albumin- 1001020.  Serum creatinine, urea and uric acid 
concentration were also measured utilizing commercial kits 
(Spinreact, Spain, refs; creatinine-1001113, urea-1001333 and uric 
acid 1001032). 






Urinary urea, uric acid concentration and proteinuria excretion were 
measured utilizing commercial kits (Spinreact, Spain, refs; urea-
1001333, uric acid 1001032 and proteinury- 100129). 
 
 
Kidney zinc analyses 
 
Dried kidney was heated in silica crucibles at 480°C for 48 h and 
the ash taken up in hot hydrochloric acid (11.7 M) for Zn analyses. 
Kidney zinc concentration was determined by atomic absorption 
spectrophotometer (Pye Unicam SP 9000 Hitchin, UK) after twenty-
fold dilution with doubly distilled water. The accuracy of zinc 
recovery was checked using standard reference materials; bovine 
liver and wheat flour. These standards were prepared and analysed 
in similar conditions to the test items to assess recovery. The 
recovery of zinc in the standard reference material exceeded 96%. 
 
 
Antioxidant parameters estimations 
 
Preparation of homogenates 
 
About 0.5 g of kidney was homogenized in 2 ml of buffer solution of 
phosphate buffer saline 1:2 (w/v; 1g tissue 2ml TBS, pH=7.4). 
Homogenates were centrifuged at 10000xg for 15 min at 4°C, and 
the obtained supernatant was used for the determination of 
antioxidant enzyme activity. 
 
 
Determination of malondialdehyde (MDA) 
 
Kidney homogenates were prepared at 10% (w/v) in 0.1 mol/L Tris-
HCl buffer, pH 7.4, and MDA steady-state level was determined. 
MDA was measured according to the method described by Sastre 
et al. (2000). Thiobarbituric acid 0.67% (w/v) was added to aliquots 
of the homogenate previously precipitated with 10% trichloroacetic 
acid (w/v). Then the mixture was centrifuged, and the supernatant 
was heated (100°C) for 15 min in a boiling water bath. After cooling, 
n-butanol was added to neutralize the mixture, and the absorbance 




Estimation of reduced glutathione (GSH) level  
 
The GSH content of kidney homogenates was measured by the 
method of Ellman (1959). 0.5 g of fresh kidney was homogenized in 
3 volumes of 5% TCA using Dounce homogenizer. The samples 
were centrifuged at 2000 rpm for 15 min. The supernatant (50μl) 
was diluted in 10 ml phosphate buffer (0.1 M, pH 8). Consequently, 
20 μl of DTNB 0.01 M was added to 3 ml of the dilution mixture. 
The measurement was performed at 412 nm against a control 
prepared in the same conditions using 5% TCA. The concentration 
is expressed in mmoles of GSH / g of kidney. They are deducted 
from a range of glutathione (GSH), which was prepared with the 
same conditions as dosage did. 
 
 
Assay of catalase (CAT) activity  
 
The activity of catalase was estimated according to the method of 
Clairborne (1985). Determination of CAT activity depends on 
changes in absorbance result from the decomposition of H2O2 by 
CAT. This change is measured at 240 nm every min for 2 min. 







Protein concentration in the kidney homogenates was determined 
by Bradford method, using bovine serum albumin (BSA) as a 





One-way analysis of variance (ANOVA) followed by post hoc 
Tukey-HSD test were used for data analysis. Results are presented 








Figure 1 shows that blood glucose (p < 0.001) values 
were higher in ZD group than in AZ group. Blood glucose 
(p < 0.001) values were significantly lower in ZD + VE 
and ZD + VC groups in comparison with ZD group. Com-
bined vitamin E and vitamin C treatements significantly 
reduced blood glucose (p < 0.001) when we compared to 
ZD group and (p < 0.05) when compared with ZD + VE. 
 
 
Body and kidney weights 
 
Figure 2 shows that there was marked reduction in the 
body weight of diabetic animals fed low zinc diet 
compared to that of AZ group (p < 0.05). In addition, 
absolute kidney weight in ZD group was significantly 
increased (p < 0.01). Oral administration of vitamin E and 
C increased the body weight compared to ZD group. 
Moreover, vitamins treatment led to significant reduction 





The concentration of zinc in kidney is shown in Figure 3 
for all studied groups. The concentration was significantly 
lower in the ZD group than in the AZ group (p < 0.001) 
and significantly higher in ZD + VE (p < 0.05), ZD + VC (p 
< 0.001) groups compared to ZD group.  
Combined vitamin E and vitamin C treatements 
significantly elevated kidney zinc status (p < 0.001) 
compared to ZD group and a significant rise in kidney 
zinc concentrations compared to ZD + VE (p < 0.05) and 
ZD + VC (p < 0.01) groups. 
 
 
Blood biochemical values 
 
Serum albumin, total protein, creatinine, urea and uric 
acid values are shown in Table 1. Serum albumin (p < 
0.05) and total protein (p < 0.01) values were lower in ZD 
group than in AZ group. In contrast, creatinine (p < 0.001),






Figure 1. Blood glucose concentration in diabetic rats fed (AZ), (ZD) diets, (ZD+VE), (ZD+VC) and (ZD+VC+VE) 
after four weeks of treatment. Statistically significant differences from AZ:  ***p < 0.001; from ZD:
 c
p<0.001; from ZD+ 
(VE+V C):  
µ




Table 1. Serum albumin and creatinine levels, Urinary volume, Serum and urinary protein, urea and uric acid concentration of AZ, ZD, 
ZD+VE, ZD+VC and ZD+ (VE+VC) groups after four weeks of treatment. 
 
Parameter 
Experimental groups (n=8) 
AZ ZD ZD+VE ZD+VC ZD+ (VE +VC) 
Serum      





































      
Urine      




























Statistically significant differences from AZ: *P < 0.05, **P < 0.01, ***P < 0.001; from ZD:
 a
P < 0.05, 
b
P < 0.01, 
c








urea (p < 0.001) and uric acid (p < 0.01) values were 
higher than those of AZ rats. Serum albumin (p < 0.01 
and p < 0.001) and total protein (p < 0.001) values were 
significantly higher in ZD + VE and ZD + VC groups in 
comparison with ZD group. Meanwhile creatinine (p < 
0.001 and p < 0. 01), urea (p < 0.001) and uric acid (p < 
0.01 and p < 0.05) values were lower in these two groups 
(ZD + VE and ZD + VC). Moreover combined vitamin E 
and vitamin C treatements significantly reduced 
creatinine (p < 0.001), urea (p < 0.05) and uric acid (p < 
0.001) and elevated serum albumin (p < 0.01) and total 
protein (p < 0.001) values compared to ZD group, but 
administration of vitamin E and vitamin C in association 
improved creatinine (p < 0.05 and p < 0.001), urea (p < 















































































Figure 2. Body (A) and absolute kidney weight (B) of diabetic rats fed (AZ), (ZD) diets, (ZD+VE), 
(ZD+VC) and (ZD+VC+VE) after four weeks of treatment. Statistically significant differences from AZ: 
*p < 0.05, **p < 0.01; from ZD:
 a
p < 0.05, 
b
P < 0.01, 
c
p<0.001; from ZD+ (VE+V C):  
µ
P<0.05.  Values 




0.001 and p < 0.001), uric acid (p < 0.001) and serum 




Urinary biochemical values 
 
Urinary protein, urea and uric acid values are shown in 
Table 1. Urinary protein (p < 0.05), urea (p < 0.01) and 
uric acid (p < 0.01) values were higher in ZD group than 
in AZ group. Urinary protein (p < 0.05 and p < 0.01), urea 
(p < 0.01 and p < 0.05) and uric acid (p < 0.05) values 
were lower in (ZD + VE and ZD + VC) groups respec-
tively in comparison with ZD group. Moreover combined 
vitamin E and vitamin C treatements reduced, urea (p < 
0.05) and uric acid (p < 0.05) concentrations compared to 
ZD group and improved urinary protein exerition (p < 
0.05)  in comparison with (ZD+VC). 






Figure 3. Kidney zinc level in diabetic rats fed (AZ), (ZD) diets, (ZD+VE), (ZD+VC) and ZD+(VC+VE) after 
four weeks of treatment. Statistically significant differences from AZ: ***p < 0.001; from ZD:
 a
p < 0.05, 
c









Oxidative stress parameters  
 
MDA concentration was significantly higher in diabetic 
animals fed low zinc diet as compared to the adequate 
zinc group (P < 0.05), but markedly declined after vitamin 
E and vitamin C administration (P < 0.05) compared to 
ZD group (Figure 4). Also, there was a marked decrease 
in the GSH level (p < 0.01), and CAT (p < 0.01) activity in 
ZD rats as compared to AZ group. There was a 
significant rise of GSH level (p < 0.01) and CAT activity (p 
< 0.05 and p < 0. 01), in kidney of diabetic rats fed zinc 
deficient diet after vitamin E and vitamin C administration 
(Figure 4).  
In addition administration of vitamin E and vitamin C in 
association reduced in part MDA and elevated GSH 
concentrations (p < 0.01), and CAT  (p < 0.05) activity 
compared with ZD group, on the other part ameliorated 
CAT activity (p < 0.05) when compared with (ZD+VE) or 





The result of this study showed that there were marked 
reductions in the total body weight as well as elevation in 
the absolute kidney weight of rats fed the zinc deficient 
diet (ZD) compared with rats fed the adequate zinc diet 
(AZ). It was reported that growth retardation was common 
in zinc defficient bull calves this was due in part to 
decreased appetite and impaired protéin synthesis. Sun 
et al. (2006) reported that the relative weight of kidney 
increased by a zinc deficient diet and found that ZD diet 
influence organ development. Administration of vitamin C 
and /or vitamin E minimized body weight loss observed in 
diabetic rats fed low zinc diet and ameliorated both body 
and kidney weights. 
Blood glucose was affected by low zinc diet. The 
observed higher blood glucose in the present study of low 
zinc animals may relate to altered glucose utilisation by 
tissues or to the increased rate of endogenous glucose 
production (Hendricks and Mahoney, 1972). The result of 
this study and those of previous studies show that vitamin 
E and vitamin C reduce blood glucose levels in diabetic 
animals. However, vitamin E as an antioxidant may help 
in the clearance of free radicals responsible for the 
complications of diabetes mellitus. In addition, it may also 
promote the absorption or uptake of glucose from the 
intestine and cells, respectively (Al Shamsi et al., 2004). 
Vitamin C was reported to help in improving plasma glu-
cose in patients with type 2 diabetes (Afkhami and 
Shojaoddiny, 2007).  
Several studies clearly demonstrated that hyperglyce-
mia is an important causal factor in the development and 
progression of diabetic kidney disease (Haidara et al., 
2009). The diabetic hyperglycemia induces elevation of 
serum levels of urea, uric acid and creatinine which are 
considered as significant markers of renal dysfunction 
(Shind and Goyal, 2003). Our results show significant
























































Figure 4. Kidney MDA (A) and GSH levels (B) and CAT activity (C) of AZ, ZD, 
ZD+VE, ZD+VC and ZD+ (VE+VC) groups after four weeks of treatment. 





p < 0.01; from ZD+ (VE+V C):  
µ
p<0.05.  Values are given as mean ±SEM for 





increase in the level of serum urea, uric acid and 
creatinine in the diabetic rats fed low zinc diet. These 
results indicated that zinc deficiency elevated renal 
markers (serum urea nitrogen, uric acid and creatinine), 
which are found responsible for proper maintenance, 
functioning of kidney and change in the glomerular 
filtration rate (Mauer et al., 1981). 
Our experimental data indicate that rats receiving a 
zinc-deficient diet had an increased rate of catabolism. 
This is based on the findings of elvated concentrations of 
urinary urea and uric acid. The production of uric acid, an 
end product of purine metabolism, can be influenced by 
altering the concentrations of substrates of nucleic acid. 
The urinary urea is the product of the hydrolytic cleavage 
of L-arginine by the enzyme arginase. The increased 
urinary urea in a zinc-deficient rat is due to the increase 
of hepatic arginase activity, which is a rate-limiting 
enzyme in urea formation (Jenc and william, 1975). Admi-
nistration of vitamin E and C improves renal markers. 
Previous studies (Sutton et al., 1983; Mitch et al., 1981) 
suggest that vitamin C exerts a uricosuric effect by 
increasing urinary excretion and reducing serum concen-
trations of uric acid that at high levels could become 
crystallized in the joint and kidney and lead to gout and 
kidney stones. 
Several studies have described biological mechanisms 
by which vitamin C reduces serum uric acid. In vivo 
studies suggest that vitamin C has uricosuric properties, 
increasing renal fractional clearance of uric acid, thereby 
reducing serum uric acid (Stein et al., 1976). This is likely 
due to competitive inhibition of an anion exchange 
transport system at the proximal tubule in the nephron 
(Berger et al., 1977). It is also possible that vitamin C 
increases the glomerular filtration rate by reducing glome-
rular microvascular ischemia and increasing dilatation of 
afferent arterioles (Huang et al., 2005).   
In this experiment there was a significant reduction of 
kidney zinc, serum albumin and total protein 
concentration, but urinary protein excretion was elevated 
in zinc deficient group. A significant decrease in total 
protein level might be due to catabolism of protein and/ or 
malfunction of liver (Harper et al., 1977). In addition, 
changes in the binding of zinc to plasma proteins may 
result in an increase in ultrafilterable zinc concentration 
(Prasad and Oberleas, 1970). Administration of vitamins 
C and E decreased urinary protein and improves renal 
damage. These results are in agreement with the results 
of previous studies (Eun et al., 2007). 
In the present study, GSH level and CAT activity were 
measured in renal tissue to evaluate the changes of 
antioxidant status in the kidney. Increased renal MDA 
content and decreased GSH level and CAT activity were 
found in diabetic rats fed low zinc diet compared to the 
AZ group. However, administration of vitamin E and C 
alone or in combination significantly improved these 
parameters. These vitamins may exert their beneficial 
effects through antioxidant action (Sadi et al., 2012). 
Vitamin  C  also  acts  as  an  aldose  reductase  inhibitor  




reducing sorbitol conversion and decreasing cellular 
damage in the kidney (Vincent, 1999). Vitamin E, on the 
other hand, acts as a non-enzymatic antioxidant and 
reduces lipid peroxidation and glutathione (Punithavatki 





Our data shows that vitamin C or vitamin E alone and a 
combination of them preserved renal antioxidant levels 
and prevented kidney damage. The decreases in urinary 
protein excretion and the improvement in renal function in 
antioxidant vitamins treated groups suggest a major role 
of oxidative stress in the developing of renal dysfunction 
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